Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biosip AB maintains 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution of this portfolio is highly concentrated, as it involves only 1 distinct examiner and 1 distinct art unit. This suggests that the company's current patenting activity is focused on a specific technical niche within the broader biotech field. The involvement of a single art unit indicates that the technical review is confined to a single specialized group.
SINGH, ANOOP KUMAR is the busiest examiner for the portfolio, with 1 pending office action. This examiner is responsible for the total volume of the company's current pending matters. With only 1 distinct art unit involved, the administrative scope of the prosecution is limited to a single group. This concentration means that the outcome of the 1 pending action will define the company's immediate success in this technology area. Practitioners can observe that the specific art unit involved defines the administrative variety of the prosecution process. The oversight by SINGH, ANOOP KUMAR suggests a singular point of contact for the company's current biotechnology interests.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SINGH, ANOOP KUMAR | 1 | 43.0% | +67.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270787 | LIPID LAYER PRESERVATION | SINGH, ANOOP KUMAR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270787 | LIPID LAYER PRESERVATION | SINGH, ANOOP KUMAR | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18270787 | LIPID LAYER PRESERVATION | SINGH, ANOOP KUMAR | 1632 | §102§103 | Non-Final OA | — | Pending | Jul 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial